News
Latest News, Announcements, and Press Releases
29Oct 20
Codexis to Hold Third Quarter 2020 Conference Call on November 5
REDWOOD CITY, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that it will report third quarter 2020 financial results after market close on Thursday, November 5, 2020 . Codexis management…
read more08Sep 20
Codexis to Present at Two Virtual Investment Conferences in September
REDWOOD CITY, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming virtual investment conferences: H.C. Wainwright 22 nd Annual Global Investment Conference on…
read more06Aug 20
Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors
REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker , Ph.D. to its board of directors, expanding membership…
read more01Aug 20
Codexis Reports Second Quarter 2020 Financial Results
Revenues increased 21% to $15 million ; 72% rise in R&D revenue included a significant contribution from the Takeda biotherapeutics partnership Conference call with slides begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE…
read more30Jul 20
Codexis to Hold Second Quarter 2020 Conference Call on August 6
REDWOOD CITY, Calif. , July 30, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020 . Codexis management…
read more23Jun 20
Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
Partnership targets accelerating the commercialization of enzymatic DNA synthesis: Codexis invests cash and protein engineering for equity stake in Molecular Assemblies REDWOOD CITY, Calif. and SAN DIEGO , June 23, 2020 (GLOBE NEWSWIRE) — Codexis, Inc.
read more16Jun 20
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
REDWOOD CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new independent directors, Alison Moore , Ph.D. and Stephen Dilly , MBBS,…
read more01Jun 20
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
First enzymes will target NGS-based diagnostics, RNA-directed viral diagnostics and RNA manufacturing REDWOOD CITY, Calif. and JUPITER, Fla. , June 01, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and
read more27May 20
Codexis to Participate in Two Virtual Investment Conferences
REDWOOD CITY, Calif. , May 27, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment conferences: 17 th Annual Craig-Hallum Institutional Investor Conference being held in a…
read more11May 20
Codexis to Present at the UBS Virtual Healthcare Conference
REDWOOD CITY, Calif. , May 11, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare Conference on Monday, May 18 at 9:10 a.m. Eastern time (…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries